Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study

• Main Authors: Nicolas Folschweiller, Julio Teixeira, Smita Joshi, Luciano Z. Goldani, Khuanchai Supparatpinyo, Partha Basu, Tawee Chotpitayasunondh, Ploenchan Chetchotisakd, Kiat Ruxrungtham, Cecilia Roteli-Martins, Beatriz Grinsztejn, Silvana Maria Quintana, Nagalingeswaran Kumarasamy, Selvamuthu Poongulali, Vinay Kulkarni, Lan Lin, Sanjoy K. Datta, Dominique Descamps, Monique Dodet, Gary Dubin, Damien Friel, Marjan Hezareh, Naveen Karkada, Dorothee Meric Camilleri, Sylviane Poncelet, Bruno Salaun, Fernanda Tavares-da-Silva, Florence Thomas-Jooris, Frank Struyf
• Format: Journal
• Published: 2020
• Subjects: Medicine
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086842475&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/70852
• Institution: Chiang Mai University

© 2020 The Author(s) Background: Women living with HIV (WLWH) are at higher risk of acquisition and progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination in this population is limited. Methods: This phase IV randomized controlled observer-blind study assessed imm...